Brief: MediPharm Labs Australia Enters Supply Agreement With Vivo Cannabis, Prepares To Start Sales
19/06/2020 12:17
June 19 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS AUSTRALIA ENTERS INTO NEW SUPPLY AGREEMENT
WITH
VIVO CANNABIS AND PREPARES TO COMMENCE SALES
* MEDIPHARM LABS CORP - MEDIPHARM LABS AUSTRALIA TO SUPPLY
FULL
RANGE OF GMP-CERTIFIED, FORMULATED CBD, THC CANNABIS OIL
PRODUCTS TO BEACON MEDICAL AUSTRALIA
* MEDIPHARM LABS CORP - AGREEMENT HAS AN INITIAL ONE-YEAR
TERM
SUBJECT TO RENEWAL
Source text for Eikon: ID:nGNX765yVC
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue